KR860001024B1 - Process for preparing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid esters - Google Patents
Process for preparing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid esters Download PDFInfo
- Publication number
- KR860001024B1 KR860001024B1 KR1019840000616A KR840000616A KR860001024B1 KR 860001024 B1 KR860001024 B1 KR 860001024B1 KR 1019840000616 A KR1019840000616 A KR 1019840000616A KR 840000616 A KR840000616 A KR 840000616A KR 860001024 B1 KR860001024 B1 KR 860001024B1
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- methoxy
- chlorobenzoyl
- added
- preparing
- Prior art date
Links
- 0 C*(*1c(C)[n](C(c(cc2)ccc2Cl)=O)c(CC2)c1CC2OC)=O Chemical compound C*(*1c(C)[n](C(c(cc2)ccc2Cl)=O)c(CC2)c1CC2OC)=O 0.000 description 1
Abstract
Description
본 발명은 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산에스테르의 신규 제조방법에 관한 것이다.The present invention relates to a novel process for preparing 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indoleacetic acid ester.
상기 구조식 (Ⅰ)에서 R은 알킬기, 알케닐기, 알콕시알킬기, 치환아릴기, 아릴기, 아릴알킬기 및 사이클로 알킬기를 나타낸다. 이중 특히 유용한 것은 p-아세틸 아미노페릴, 2-카복시페닐, 2-메톡시 카보닐페닐, 카복시 메틸 등이다.R in the formula (I) represents an alkyl group, an alkenyl group, an alkoxyalkyl group, a substituted aryl group, an aryl group, an arylalkyl group and a cycloalkyl group. Particularly useful among these are p-acetyl aminoferyl, 2-carboxyphenyl, 2-methoxy carbonylphenyl, carboxy methyl and the like.
상기 화합물은 비스테로이드성 진통소염제로서 기존 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산에 비해 위장장해가 크게 감소된 것으로 알려져 있다.The compound is a nonsteroidal analgesic anti-inflammatory agent, it is known that the gastrointestinal disorder is greatly reduced compared to the existing 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indoleacetic acid.
지금까지 알려진 화합물 (Ⅰ)의 제조방법으로서는,As a manufacturing method of the compound (I) known so far,
첫째, Spain 341,692호 동 423,833호 및 432,544호 미국특허 제 4,014,997 등에 기재된1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산과 티오닐 클로라이드를 반응시켜 산 염화물 형태의 중간체를 얻은 후 여기에 알콜을 부가하여 화합물(Ⅰ)을 제조하는 방법이 있고 둘째, 미국특허 제3,770,752호 벨기에 특허 제649,169호 등에 기재된1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산을 N,N-디사이클로헥실카보디 이미드를 사용하여 축합시켜 산무수물 형태의 중산체를 얻은 후 여기에 알콜을 부가하여 화합물(Ⅰ)을 제조하는 방법등이 알려져 있다. 그러나 첫째 방법으 경우 인체에 유독한 벤젠과 티오닐 클로라이드를 사용해야 되므로 공업화시 안전상에 문제가 있고First, the reaction of l- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indoleacetic acid with thionyl chloride as described in Spain 341,692, 423,833 and 432,544, U.S. Pat. After obtaining the intermediate, there is a method of preparing compound (I) by adding alcohol thereto, and secondly, 1- (4-chlorobenzoyl) -5-methoxy-2- as described in US Pat. No. 3,770,752 and Belgian Patent 649,169, etc. A method of preparing compound (I) by condensation of methyl-3-indolacetic acid using N, N-dicyclohexylcarbodiimide to obtain an acid anhydride in the form of an acid anhydride is added thereto. . However, in case of the first method, it is necessary to use benzene and thionyl chloride, which are toxic to human body.
둘째 방법의 경우 최종 단계에서 화합물(Ⅰ)과 함께 출발물질인 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산이 생성되므로 최종물질의 정제와 출발물질의 회수가 어려우므로 수율이 저하되는 단점이 있다.In the case of the second method, since the starting material 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indolacetic acid is produced together with the compound (I) in the final step, purification of the final material and recovery of the starting material It is difficult to have a disadvantage in that the yield is lowered.
그러므로 본 발명에서는 우선 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산과 5-메틸-2-머캅토-1,3,4-티아디아졸을 반응시켜 티오에스테르(Ⅱ)를 중간체로 얻고 여기에 일반식(Ⅳ)의 알콜을 부가하여 화합물(Ⅰ)을 고수율로 얻고 반응용매도 인체에 유독한 벤젠대신 디클로로메탄을 사용하므로 상기 첫째 및 둘째 방법의 단점을 제거시킬 수 있었다.Therefore, in the present invention, first, 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indoleacetic acid and 5-methyl-2-mercapto-1,3,4-thiadiazole are reacted. The disadvantages of the first and second methods are obtained by obtaining the ester (II) as an intermediate and adding the alcohol of the general formula (IV) to the high yield and the reaction solvent using dichloromethane instead of benzene, which is toxic to the human body. Could be removed.
본 발명의 내용을 구조식으로 도식하면 다음과 같다.When the content of the present invention is represented by the structural formula as follows.
본 발명의 비한정적 실시예는 다음과 같다.Non-limiting examples of the invention are as follows.
[실시예 1]Example 1
2'-(5'-메틸-1',3',4'-티아디아졸릴-1-(4-클로로벤조일)-5-메톡시-2-메틸-1H-3-인돌 티오아세테이트 제조방법Process for preparing 2 '-(5'-methyl-1', 3 ', 4'-thiadiazolyl-1- (4-chlorobenzoyl) -5-methoxy-2-methyl-1H-3-indole thioacetate
500ml 3구 플라스크에 온도계를 부착하고 디클로로메탄 300ml를 넣고 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌초산 10.73g(0.03몰) 5-메틸-2-머캅토-1,3,4-티아디아졸 3.96g(0.03몰)을 가하여 교반 용해시킨다.Attach a thermometer to a 500 ml three-necked flask, add 300 ml of dichloromethane, and add 10.73 g (0.03 mol) of 5-methyl-2-mercapto 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indolacetic acid. 3.96 g (0.03 mol) of -1,3,4-thiadiazole are added and dissolved by stirring.
여기에 N,N-디사이크로 헥실카보디 이미디 7.18g(0.035몰)과 4-(디메틸아미노) 피리딘 소량을 가한뒤 동 온도에서 6시간 교반하여 반응시킨다. 불용물을 여과하여 제거하고 여액을 감압 농축하여 14.02g(수득율 : 99.0%) 노란색 결정을 얻었다.7.18 g (0.035 mole) of hexyl carbodiimide and a small amount of 4- (dimethylamino) pyridine were added thereto, followed by stirring at the same temperature for 6 hours. The insolubles were removed by filtration and the filtrate was concentrated under reduced pressure to give 14.02 g (yield: 99.0%) of yellow crystals.
IR (KBr) 1740(CH2CO)cm-1 IR (KBr) 1740 (CH 2 CO) cm -1
NMR (CDCl3) 2.38 (s, 3H, CH3), 2.42 (s, 3H, CH3)NMR (CDCl 3 ) 2.38 (s, 3H, CH 3 ), 2.42 (s, 3H, CH 3 )
3.8 (s, 3H, OCH3), 4.3 (s, 2H, CH2CO),3.8 (s, 3H, OCH 3 ), 4.3 (s, 2H, CH 2 CO),
6.5-8.0 (m, 7H, Ar-H) ppm(δ)6.5-8.0 (m, 7H, Ar-H) ppm (δ)
[실시예 2]Example 2
에틸 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌일아세테이트 제조 500ml 3구 플라스크에 온도계 및 냉각장치를 부착하고 에틸알콜 220ml를 넣고 티오에스테르(Ⅱ) 9.44g(0.02몰), 4-(디메틸아미노)피리딘 소량을 가하여 5시간 환류시켜 반응시킨 후 감압 농축하여 얻은 결정에 250ml 메틸알콜을 가하여 30분간 교반하고 여과하였다.Preparation of ethyl 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indolyl acetate In a 500 ml three-necked flask, a thermometer and a cooling device were attached, 220 ml of ethyl alcohol was added, and 9.44 g of thioester (II) 0.02 mole) and a small amount of 4- (dimethylamino) pyridine were added and refluxed for 5 hours to react. Then, 250 ml of methyl alcohol was added to the crystal obtained by concentrating under reduced pressure, and stirred for 30 minutes and filtered.
결정을 다시 증류수 200ml에 현탁시켜 약 30분 교반 후 여과 건조하여 7.43g의 노란색 결정을 얻었다.The crystals were again suspended in 200 ml of distilled water, stirred for about 30 minutes, and filtered and dried to obtain 7.43 g of yellow crystals.
(수득율 : 96.3%)(Yield: 96.3%)
융점 : 94.6℃Melting Point: 94.6 ℃
IR (KBr) 1725 (CH2CO)cm-1 IR (KBr) 1725 (CH 2 CO) cm -1
NMR (CDCl3) 1.3 (t, 3H, CH3), 2.46 (s, 3H, CH3)NMR (CDCl 3 ) 1.3 (t, 3H, CH 3 ), 2.46 (s, 3H, CH 3 )
3.6 (s, 2H, OCH2CO), 3.75 (s, 3H, OCH3),3.6 (s, 2H, OCH 2 CO), 3.75 (s, 3H, OCH 3 ),
4.2 (q, 2H, CH2), 6.5-8.0 (m, 7H, Ar-H) ppm(δ)4.2 (q, 2H, CH 2 ), 6.5-8.0 (m, 7H, Ar-H) ppm (δ)
[실시예 3]Example 3
푸르푸릴 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌일아세테이트 제조 100ml 3구 플라스크에 디클로로 메탄 50ml를 넣고 티오에스테르(Ⅱ) 2.83g(0.006몰) 및 4-(디메틸아미노) 피리딘 0.06g(0.0065몰)을 가하여 용해시키고 푸르푸릴 알콜 0.52ml (0.006)을 가한 후 5시간 환류시킨다. 반응액을 감압 농축한후 생성된 반고형 물질을 에틸 알콜에 용해한 후 비욕상에서 교반한다.Preparation of furfuryl 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indolyl acetate 50 ml of dichloromethane was added to a 100 ml three-necked flask, and 2.83 g (0.006 mol) of thioester (II) and 4- 0.06 g (0.0065 mol) of (dimethylamino) pyridine is added to dissolve, and 0.52 ml (0.006) of furfuryl alcohol is added and refluxed for 5 hours. The reaction solution is concentrated under reduced pressure, and the resulting semi-solid substance is dissolved in ethyl alcohol and stirred in a non-bath.
여기서 생성된 결정을 여과후 물에 현탁시키고 다시 여과하여 1.29g(49.1%)의 연미색 결정을 얻었다.The resulting crystals were filtered, suspended in water, and filtered again to give 1.29 g (49.1%) of pale yellow crystals.
융점 : 101℃Melting Point: 101 ℃
IR (KBr) 1730 (CH2CO)cm-1 IR (KBr) 1730 (CH 2 CO) cm -1
NMR (CDCl3) 2.35 (s, 3H, CH3), 3.7 (s, 2H, CH2CO),NMR (CDCl 3 ) 2.35 (s, 3H, CH 3 ), 3.7 (s, 2H, CH 2 CO),
3.81 (s, 3H, CH3O), 5.1 (s, 2H, OCH2),3.81 (s, 3H, CH 3 O), 5.1 (s, 2H, OCH 2 ),
6.4 (m, 2H, CH), 6.74 (m, 1H, OCH=),6.4 (m, 2H, CH), 6.74 (m, 1H, OCH =),
6.5-7.8 (m, 3H, Ar-H) ppm(δ)6.5-7.8 (m, 3H, Ar-H) ppm (δ)
[실시예 4]Example 4
2'-카복시페닐 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌일아세테이트 제조 500ml 3구 플라스크에 냉각 장치를 부착한후 디클로로 메탄 220ml을 넣고 태오에스테르(Ⅱ) 9.44g(0.02몰), 살리실산 3.59g(0.024)과 4-(디메틸아미노) 피리딘 소량을 가하여 7시간 환류시킨다.Preparation of 2'-carboxyphenyl 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indolyl acetate After attaching a cooling device to a 500 ml three-necked flask, 220 ml of dichloromethane was added thereto and then thioester (II) 9.44 g (0.02 mol), salicylic acid 3.59 g (0.024) and a small amount of 4- (dimethylamino) pyridine are added and refluxed for 7 hours.
반응액을 감압 농축한 후 여기에 200ml의 에틸알콜을 가하여 1시간 교반하고 여과한다. 결정을 종류수에 현탁하여 1시간 교반한 후 여과 건조하여 4.43g(수득율 : 46.3%)의 백색 결정을 얻었다.The reaction solution was concentrated under reduced pressure, 200 ml of ethyl alcohol was added thereto, stirred for 1 hour, and filtered. The crystals were suspended in water and stirred for 1 hour, followed by filtration and drying to obtain 4.43 g (yield: 46.3%) of white crystals.
융점 : 182.1℃Melting Point: 182.1 ℃
IR (KBr) 1750 (CH2CO) cm-1 IR (KBr) 1750 (CH 2 CO) cm -1
NMR (CDCl3) 2.40 (s, 3H, CH3), 3.83 (s, 3H, OCH3),NMR (CDCl 3 ) 2.40 (s, 3H, CH 3 ), 3.83 (s, 3H, OCH 3 ),
3.96 (s, 2H, CH2CO), 6.8-8.0 (m, 11H, Ar-H) ppm(δ)3.96 (s, 2H, CH 2 CO), 6.8-8.0 (m, 11H, Ar-H) ppm (δ)
[실시예 5]Example 5
p-아세트아미노페닐 1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌아세테이트의 제조Preparation of p-acetaminophenyl 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indoleacetate
200ml 3구 플라스크에 디클로로 메탄 100ml를 넣고 티오에스테르(Ⅱ)3.96g(0.0084몰), 아세트 아미노펜 1.3g(0.0084몰)과 4-(디메틸아미노) 피리딘 소량을 가하여 6시간 환류시킨다.100 ml of dichloromethane was added to a 200 ml three-necked flask, and 3.96 g (0.0084 mol) of thioester (II), 1.3 g (0.0084 mol) of acetaminophen and a small amount of 4- (dimethylamino) pyridine were added and refluxed for 6 hours.
반응액을 감압 농축한후 여기에 50ml의 에틸알콜과 50ml의 증류수를 가하여 1시간 교반하고 여과한다.The reaction solution was concentrated under reduced pressure, 50 ml of ethyl alcohol and 50 ml of distilled water were added thereto, stirred for 1 hour, and filtered.
건조후 1.95g(수득율 47.5%)의 연미색 결정을 얻었다.After drying, 1.95 g (yield 47.5%) of pale brown crystals were obtained.
융점 : 169.2℃Melting Point: 169.2 ℃
IR (KBr) 1750 (CH2CO)cm-1 IR (KBr) 1750 (CH 2 CO) cm -1
NMR (CDCl3) 2.1 (s, 3H, CH3CO), 2.45 (s, 3H, CH3),NMR (CDCl 3 ) 2.1 (s, 3H, CH 3 CO), 2.45 (s, 3H, CH 3 ),
3.85 (s, 5H, CH3CO & OCH3), 6.5-8.0 (m, 11H, Ar-H) ppm(δ)3.85 (s, 5H, CH 3 CO & OCH 3 ), 6.5-8.0 (m, 11H, Ar-H) ppm (δ)
[실시예 6]Example 6
1-(4-클로로벤조일)-5-메톡시-2-메틸-3-인돌아세톡시초산의 제조 200ml 3구 플라스크에 건조관을 연결하고 디클로로 메탄 100ml를 가한다. 여기에 티오에스테르(Ⅱ) 2.36g(0.005몰) 및 무수글리콜산 0.38g(0.005몰)을 가하고 소량의 4-(디메틸아미노) 피리딘을 가한다.Preparation of 1- (4-chlorobenzoyl) -5-methoxy-2-methyl-3-indoleacetoxyacetic acid To a 200 ml three-necked flask was connected a dry tube and 100 ml of dichloromethane were added. To this was added 2.36 g (0.005 mol) of thioester (II) and 0.38 g (0.005 mol) of glycolic anhydride and a small amount of 4- (dimethylamino) pyridine.
반응색을 상온에서 5시간 교반시킨 후 감압 농축한다.The reaction color was stirred at room temperature for 5 hours and then concentrated under reduced pressure.
여기서 얻은 연미색 농축잔사에 초산 에틸 50ml를 가하여 용해시키고 여기에 석유 에테르 30ml를 가한다.50 ml of ethyl acetate is added to the light brown concentrated residue thus obtained, and 30 ml of petroleum ether is added thereto.
상온에서 30분간 교반후 12시간 냉각 방치한 결과 1.08g의 연미색 결정을 얻었다.(수득율 : 51.9%)After stirring for 30 minutes at room temperature and cooling for 12 hours, 1.08 g of pale yellow crystals were obtained. (Yield: 51.9%)
융점 : 151℃Melting Point: 151 ℃
IR (KBr) 3110(OH), 1748 (CH2CO)cm-1 IR (KBr) 3110 (OH), 1748 (CH 2 CO) cm -1
NMR (CDCl3) 2.33 (s, 3H, CH3), 3.74 (s, 2H, CH2CO),NMR (CDCl 3 ) 2.33 (s, 3H, CH 3 ), 3.74 (s, 2H, CH 2 CO),
3.77 (s, 3H, OCH3), 4.62 (s, 2H, -OCH2CO)3.77 (s, 3H, OCH 3 ), 4.62 (s, 2H, -OCH 2 CO)
8.67 (s, 1 H, COOH), 6.5-7.0 (m, 7H, Ar-H) ppm(δ)8.67 (s, 1H, COOH), 6.5-7.0 (m, 7H, Ar-H) ppm (δ)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019840000616A KR860001024B1 (en) | 1984-02-10 | 1984-02-10 | Process for preparing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid esters |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019840000616A KR860001024B1 (en) | 1984-02-10 | 1984-02-10 | Process for preparing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid esters |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850005823A KR850005823A (en) | 1985-09-26 |
KR860001024B1 true KR860001024B1 (en) | 1986-07-28 |
Family
ID=19232831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840000616A KR860001024B1 (en) | 1984-02-10 | 1984-02-10 | Process for preparing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid esters |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR860001024B1 (en) |
-
1984
- 1984-02-10 KR KR1019840000616A patent/KR860001024B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR850005823A (en) | 1985-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR860001024B1 (en) | Process for preparing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid esters | |
KR0171047B1 (en) | Process for preparing anthracyclinones | |
US4599406A (en) | Process for preparing 2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide derivatives and intermediates therefor | |
FI64166B (en) | NYTT FOERFARANDE OCH MELLANPROTUKT FOER FRAMSTAELLNING AV S-TRIETYLFOSFINGULD-2,3,4,6-TETRA-0-ACETYL-1-THIO-BETA-D-GLUCOPYRANOSIDE (AURANOFIN) | |
US4277607A (en) | Process for the preparation of 4-chloroquinolines | |
US2894977A (en) | Process of preparing phenoxycinnamic acid derivatives | |
EP0202625A2 (en) | Process for the preparation of 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-(N-benzyl-N-methylamino)-ethyl ester 5-methyl ester and its hydrochloride salt | |
US4324903A (en) | Malonic esters | |
SU1034605A3 (en) | Process for preparing molecular compound of beta-diethylaminoethylamide of n-chloroacetic phenoxy acid with 4-n-butyl-3,5-diketo-1,2-diphenylpyrazolidine | |
CN108863899B (en) | Synthetic method and application of indoline-2-ketone compound | |
CA1272213A (en) | Process for inverting the configuration of optically active compounds, and optically active intermediates produced in this process | |
KR810000881B1 (en) | Process for preparing uricil derivatives | |
KR910005232B1 (en) | Process for rpoducing 1-4 dihydro pyridine carboxylic acids | |
SU567402A3 (en) | Method of preparation of quinoline derivatives and salts thereof | |
KR820000210B1 (en) | Process for preparation of -oxo-1,1'-biphenyl-4-butanoic acid | |
JP3735662B2 (en) | Hydroxyester compound and method for producing the same | |
US4524203A (en) | 4-(4-Pyridinyl)isatoic anhydride | |
KR850001698B1 (en) | Process for the preparation of 2-dialkylamino-2-phenyl-n-buthyl-3',4',5'-trimethoxybenzoic derivatives | |
KR910006981B1 (en) | Process for the preparation of carboxylate chlorate roxatidine | |
KR920003898B1 (en) | Process for preparing 3,4-dehydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxy-1,1-deoxide | |
JPS5888361A (en) | 3-amino-1,4-bis(alkoxycarbonyl)maleimide compound and its preparation | |
JPS59148770A (en) | 2,4-dichloro-5-thiazole carboxaldehyde and manufacture | |
KR800000383B1 (en) | Preparing process for 3-isoxazoly urea derivatives | |
KR860001025B1 (en) | Process for preparing 3-indol acetohydroxamic acid derivatives | |
KR800000380B1 (en) | Preparing process for 3-isoxazolyl urea derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19890726 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |